New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2012
16:16 EDTMYGN, TSL, AZN, STP, NSRGY, TRGT, YGE, TIF, RIO, BHPOn The Fly: Closing Wrap
Stocks on Wall Street were lower on concerns of slowing growth in China. The futures barely reacted to February U.S. housing data, which showed starts were lower than expected but building permits were higher. The futures action led to a lower open for the broader market. The averages found a level in the first 30 minutes of trading where they sat and eventually began to drift higher. The market moved generally higher until the last hour of the session but the averages were never able to retake the baseline to continue their six day winning streak... ECONOMIC EVENTS: In the U.S., homebuilders began construction on a seasonally adjusted annual rate of 698,000 homes in February, down 1.1% from a month ago. Building permits jumped 5.1%, versus expectations for an increase of 0.6%. In China, a report said that home prices dropped in 45 Chinese cities last month and the country increased its gas and diesel prices for the second time in less than six weeks... MARKET NEWS: BHP Billiton (BHP) was widely quoted as stating that Chinese iron ore demand growth was "flattening," but the company came out and said that the slowdown had been discussed before and was not new information. Also, both BHP and rival Rio Tinto (RIO) confirmed plans to expand production in China even further. Still, BHP's confirmation along with other signals of a slowdown in China was attributed as a significant catalyst for today's market pull-back... Saudi Arabia said it is ready to meet any shortfalls in global oil supplies which, along with China's news, caused oil prices to fall 2%, weighing on the Energy sector of the S&P... Amazon.com (AMZN) moved up 3.67% following its $775M purchase of Kiva Systems, a maker of robots and other material handling technology... MAJOR MOVERS: Among the notable gainers was Tiffany (TIF), up $4.59, or 6.68%, to $73.27, after its earnings missed expectations but its FY12 guidance beat the Street's view. Also higher were a number of Chinese solar companies, including Yingli Green Energy (YGE), up 46c, or 12.07%, to $4.27, Suntech (STP), up 44c, or 14.06%, to $3.57, and Trina Solar (TSL), up 61c, or 7.85%, to $8.38, following the U.S. Commerce Department's decision to impose tariffs of less than 5% on the companies, which was well below the 20% to 30% that was forecast by some analysts. Noteworthy losers included Targacept (TRGT), down $2.22, or 29.96%, to $5.19, after it abandoned plans to seek approval for a depression drug it was developing in partnership with AstraZeneca (AZN), and Myriad Genetics (MYGN), down $1.33, or 5.19%, to $24.31, after the Supreme Court ruled that two patents held by Nestle (NSRGY) for certain personalized medicine products are invalid because the patents utilize "laws of nature" without adding significant additional features to those laws... INDICES: The Dow fell 68.94, or 0.52%, to 13,170.19; the Nasdaq lost 4.17, or 0.14%, to 3,074.15; and the S&P 500 dropped 4.23, or 0.30%, to 1,405.52.
News For BHP;RIO;TIF;YGE;STP;TSL;TRGT;AZN;MYGN;NSRGY From The Last 14 Days
Check below for free stories on BHP;RIO;TIF;YGE;STP;TSL;TRGT;AZN;MYGN;NSRGY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 15, 2014
10:00 EDTTIFOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:16 EDTBHPOn The Fly: Pre-market Movers
Subscribe for More Information
08:47 EDTTIFTiffany China business poised to continue growth, says Sterne Agee
Subscribe for More Information
08:19 EDTTIFTiffany upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
08:19 EDTAZNLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
07:46 EDTBHPPotash Corp. speculated to be targeted again by BHP Billiton, Globe & Mail says
Subscribe for More Information
06:32 EDTAZNPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
05:10 EDTNSRGYNestle confirms FY14 organic growth guidance around 5%
Subscribe for More Information
05:08 EDTNSRGYNestle reports Q1 revenue CHF 20.8B vs. CHF 21.94B last year
Subscribe for More Information
April 14, 2014
18:32 EDTRIORio Tinto reports Q1 iron ore production up 8% to 66.4M tons
Rio Tinto reported Q1 production results, reporting global iron ore production of 66.4M tons, up 8% from the prior year period, with shipments of 66.7M tons. The company maintained its 2014 iron ore production guidance of 295M tons. Rio's mined copper production totaled 156.5K tons, up 17% against the prior year period, and the company maintained its mined copper expectations for 2014 at 570K tons.
07:37 EDTYGEYingli Green Energy subsidiary to sell at least 300MW solar energy systems
Subscribe for More Information
April 11, 2014
16:03 EDTTSLTrina Solar still sees FY14 module shipments 3.6GW-3.8GW
Subscribe for More Information
16:02 EDTTSLTrina Solar sees Q1 solar module shipments 540MW-570MW had seen 670MW-700MW
Subscribe for More Information
13:35 EDTNSRGYNestle chairman requires medical treatment
The Nestlé board of directors was informed yesterday that Peter Brabeck-Letmathe, chairman of the board, has been diagnosed with an illness which is curable but requires periodic medical treatment over the next six months. The company said that this does not affect Brabeck-Letmathe’s ability to carry out his role as chairman of the Nestlé board of directors and he will continue to fully exercise his duties during the treatment period. Reference Link
08:12 EDTTIFTiffany announces General Counsel to retire
Subscribe for More Information
April 10, 2014
12:04 EDTNSRGYNestle says slowdown could spark sales of underperforming units, WSJ says
Nestle plans to continue to to sell underperforming divisions as part of its on-going product-and-brand review, according to The Wall Street Journal, citing comments from CEO Paul Bulcke. CEO Bulcke said, "We are looking at our product and brand portfolio and analyzing it through a sharper, stricter lens. We are making choices about where we want to invest, where we want to improve and areas we want to divest." Reference Link
April 9, 2014
13:35 EDTNSRGYHershey melts after Goldman downgrade
Shares of chocolate maker Hershey (HSY) are falling after Goldman Sachs lowered its rating on the stock to a Sell. WHAT'S NEW: After the market closed last night, Goldman Sachs downgraded Hershey to Sell from Neutral, saying the stock is "priced for perfection" and that the company's cycle of strong earnings growth will end. Goldman lowered its price target for the stock to $90 from $105. Goldman Sachs analysts Jason English, Sean King and Manpreet Sethl were cautious on Hershey, saying that they expect the company's domestic momentum to fade. Goldman lowered its earnings per share estimates for Hershey's fiscal years 2014 through 2016 by 3%-6% to reflect lower sales and margin projections. While they said that they still perceive Hershey as a "best-in-breed company" whose international momentum will continue, the analysts believe expectations for the company are on the verge of turning more negative. OTHERS TO WATCH: Other companies in the chocolate industry include Nestle (NSRGY) and Mondelez (MDLZ), which owns Cadbury. PRICE ACTION: During afternoon trading, shares of Hershey fell $2.57 or $2.53%, to $99.15.
09:33 EDTRIO, BHPBofA/Merrill's industrial/mining analysts hold analyst/industry conference call
Subscribe for More Information
09:20 EDTTIFBofA/Merrill's retail analysts hold an analyst/industry conference call
Subscribe for More Information
07:29 EDTNSRGYKellogg speculated as Berkshire target amid volatile trading, Bloomberg says
Kellogg (K) shares have surged over last week amid speculation the company may be a takeover target for Warren Buffett’s Berkshire Hathaway (BRK.A), said Bloomberg's "Real M&A" column, which noted that Kellogg fits the financial criteria for the types of acquisitions Buffet has made in the past. Kellogg could also appeal to another food company, like PepsiCo (PEP) or Nestle (NSRGY), the report added. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use